# Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

> **NCT00150696** · PHASE3 · COMPLETED · sponsor: **Toronto Rehabilitation Institute** · enrollment: 38 (—)

## Conditions studied

- Acute Spinal Cord Injury.

## Interventions

- **DRUG:** Risedronate

## Key facts

- **NCT ID:** NCT00150696
- **Lead sponsor:** Toronto Rehabilitation Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 38 (—)
- **Last updated:** 2007-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150696, "Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00150696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*